A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis

Table 1 Correlation between the clinicopathologic characteristics and MCM3AP-AS1 expression in hepatocellular carcinoma

Characteristics		n = 80	MCM3AP-AS1		P
Characteristics		n = 80	Low expression (n = 40)	High expression (n = 40)	P
Age (y)	< 50	33	14	19	0.256
Age (y)	≥50	47	26	21	0.256
Sex	Male	65	31	34	0.390
Sex	Female	15	9	6	0.390
HBV	Absent	25	15	10	0.228
HBV	Present	55	25	30	0.228
Serum AFP level (ng/mL)	< 20	24	14	10	0.329
Serum AFP level (ng/mL)	≥20	56	26	30	0.329
Tumor size (cm)	< 5	30	21	9	0.006^*
Tumor size (cm)	≥5	50	19	31	0.006^*
No. of tumor nodules	1	66	34	32	0.556
No. of tumor nodules	≥2	14	6	8	0.556
Cirrhosis	Absent	33	19	14	0.256
Cirrhosis	Present	47	21	26	0.256
Venous infiltration	Absent	49	27	22	0.251
Venous infiltration	Present	31	13	18	0.251
Edmondson-Steiner grading	I + II	60	34	26	0.039^*
Edmondson-Steiner grading	III + IV	20	6	14	0.039^*
TNM tumor stage	I + II	61	36	25	0.004^*
TNM tumor stage	III + IV	19	4	15	0.004^*

ISSN: 1476-4598